Collagen Matrix in Oral Cancer Surgery
Postoperative Swallowing and Voice Outcomes After Collagen Matrix Reconstruction in Oral and Oropharyngeal Cancer Surgery
Postoperative Swallowing and Voice Outcomes After Collagen Matrix Reconstruction in Oral and Oropharyngeal Cancer Surgery
Sponsor study identifier
observational
33
1 country
1
Study Start
November 16, 2020
Actual (reported)Primary Completion
October 31, 2024
Actual (reported)Study Completion
March 31, 2025
Actual (reported)This study tend to evaluate postoperative phonation and swallowing after oncologic surgery of the oral cavity or oropharynx with application of a collagen matrix (Tachosil®). Patients are asked to complete a questionnaire the day before the surgery and at 1 and 6 months after.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 31, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 16, 2020
Actual (reported)October 31, 2024
Actual (reported)March 31, 2025
Actual (reported)December 21, 2025
Actual (reported)January 13, 2026
Actual (reported)Swallowing evaluation
We use the Deglutition Handicap Index questionnaire to evaluative swallowing before and after surgery. Patients completed the questionnaires the day before surgery, and at 1 month and 6 months postoperatively.
From enrollment (the day before the surgery) to 6 months postoperatively.
Voice evaluation
We use the Voice Handicap Index questionnaire to evaluate the phonatione before and after surgery. Patients completed the questionnaires the day before surgery, and at 1 month and 6 months postoperatively.
From enrollment (the day before the surgery) to 6 months postoperatively.
Length of hospital stay
Patient were ≥18 years with a histologically confirmed squamous cell carcinoma or other malignant tumor of the oral cavity and/or oropharynx with surgical resection indicated (T1-T3). The performance status was betwen 0 and 2. Patients were receiving or not receiving postoperative adjuvant radiotherapy
Participants were selected among patients presenting to the ENT department of the University Hospital of Besançon for a suspected lesion of the oral cavity or oropharynx.
Universitary Hospital of Besancon
Besançon, 25000, France
33 participants (actual enrollment reported by the registry).
First Submitted
December 21, 2025
First Posted
January 13, 2026
Study Start
November 16, 2020
Actual (reported)Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC
From the day before the surgery up to 3 weeks after surgery. The number of days between hospital admission and discharge to home was calculated.
time to oral feeding resumption
From the surgery up to two weeks.
incidence and onset of device-related complications
From the day of the surgery to one week after
Contact the study team to confirm eligibility.
Primary Completion
October 31, 2024
Actual (reported)Study Completion
March 31, 2025
Actual (reported)Last Updated
January 13, 2026
Record last verified: 2026-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: